Maria I. Herrera-Lumbreras - Publications

Metabolomics unravels subtype-specific characteristics related to neoadjuvant therapy response in breast cancer patients.

Journal: Metabolomics : Official journal of the Metabolomic Society

Published: February 24, 2023

Circulating extracellular vesicles promote recovery in a preclinical model of intracerebral hemorrhage.

Journal: Molecular therapy. Nucleic acids

Published: December 10, 2022

Proteomics Characterization of Clear Cell Renal Cell Carcinoma.

Journal: Journal of clinical medicine

Published: December 01, 2022

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma.

Journal: International journal of molecular sciences

Published: November 07, 2022

Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics.

Journal: Cancers

Published: April 20, 2022

MiRNAs in renal cell carcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 03, 2022

Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 20, 2022

Molecular characterization of triple negative breast cancer formaldehyde-fixed paraffin-embedded samples by data-independent acquisition proteomics.

Journal: Proteomics

Published: April 19, 2021